Back to CTSO
UBS Group AG CTSO Position History
Cytosorbents Corporation • Healthcare
Quarters held
7
Latest value
$32K
Q3 2026
Peak value
$108K
First seen
Q3 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q3 2025 | $108K |
| Q4 2025 | $74K |
| Q4 2025 | $46 |
| Q1 2026 | $65K |
| Q2 2026 | $48K |
| Q2 2026 | $925 |
| Q3 2026 | $32K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $32K | 8.3K | — | — |
| Q2 2026 | $925 | 2.5K | — | — |
| Q2 2026 | $48K | 128.5K | — | — |
| Q1 2026 | $65K | 115.2K | — | — |
| Q4 2025 | $46 | 72 | — | — |
| Q4 2025 | $74K | 115.2K | — | — |
| Q3 2025 | $108K | 115.2K | — | — |
Other funds holding CTSO
$3.3M
$3M
$2.7M
$1.9M
$1.9M
$1.8M